BD Diagnostic Systems began a recall of BD, Brucella melitensis Antigen on . The reason FDA records is "Febrile Antigens and Control Antisera that were released prior to August 2003 contained the 12/2000 revised insert that had incorrect testing instructions". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-0311-05
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Lee Laboratories, Inc.
- Product
- BD, Brucella melitensis Antigen
- Product code
- GSO Antigens (Febrile), Agglutination, Brucella Spp.
- Reason for recall
- Febrile Antigens and Control Antisera that were released prior to August 2003 contained the 12/2000 revised insert that had incorrect testing instructions.
- FDA root cause
- Other
- Action
- Consignees were notified by letter beginning 10/20/2004.
- Quantity in commerce
- 120 vials (5 ml per vial)
- Distribution
- Nationwide, Australia, Belgium, Canada, Chile, Ecuador, India, Korea, Malaysia, New Zealand, Singapore, Taiwan
- Product codes and lots
- Catalogue #240943, Lot #3046337
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
